Stem cell approaches for diabetes: towards beta cell replacement

por Weir, Gordon C, Cavelti-Weder, Claudia, Bonner-Weir, Susan
Publicado 2011

Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism

por Sarcevic, Jelena, Cavelti-Weder, Claudia, Berger, Christoph T., Trendelenburg, Marten
Publicado 2020

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy

por Cavelti-Weder, Claudia, Muggli, Bettina, Keller, Cornelia, Babians-Brunner, Andrea, Biason-Lauber, Anna, Donath, Marc Y., Schmid-Grendelmeier, Peter
Publicado 2012

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver

por AlAsfoor, Shefaa, Rohm, Theresa V., Bosch, Angela J. T., Dervos, Thomas, Calabrese, Diego, Matter, Matthias S., Weber, Achim, Cavelti-Weder, Claudia
Publicado 2018

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes

por Cavelti-Weder, Claudia, Furrer, Romana, Keller, Cornelia, Babians-Brunner, Andrea, Solinger, Alan M., Gast, H., Fontana, A., Donath, Marc Y., Penner, Iris K.
Publicado 2011

SAT-059 Treatment Of Primary Aldosteronism With The mTORC1 Inhibitor Everolimus

por Trinh, Beckey, Hepprich, Matthias, Betz, Matthias, Burkard, Thilo, Cavelti.Weder, Claudia, Seelig, Eleonora, Meienberg, Fabian, Kratschmar, Denise, Odermatt, Alex, Michael, Hall, Donath, Marc, Swierczynska, Marta
Publicado 2019

Diesel Exhaust Particle (DEP)-induced glucose intolerance is driven by an intestinal innate immune response and NLRP3 activation in mice

por Bosch, Angela J. T., Rohm, Theresa V., AlAsfoor, Shefaa, Low, Andy J. Y., Baumann, Zora, Parayil, Neena, Noreen, Faiza, Roux, Julien, Meier, Daniel T., Cavelti-Weder, Claudia
Publicado 2023

Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

por Cavelti-Weder, Claudia, Babians-Brunner, Andrea, Keller, Cornelia, Stahel, Marc A., Kurz-Levin, Malaika, Zayed, Hany, Solinger, Alan M., Mandrup-Poulsen, Thomas, Dinarello, Charles A., Donath, Marc Y.
Publicado 2012

Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice

por Bosch, Angela J. T., Rohm, Theresa V., AlAsfoor, Shefaa, Low, Andy J. Y., Keller, Lena, Baumann, Zora, Parayil, Neena, Stawiski, Marc, Rachid, Leila, Dervos, Thomas, Mitrovic, Sandra, Meier, Daniel T., Cavelti-Weder, Claudia
Publicado 2023

Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation

por Rohm, Theresa V., Fuchs, Regula, Müller, Rahel L., Keller, Lena, Baumann, Zora, Bosch, Angela J. T., Schneider, Romano, Labes, Danny, Langer, Igor, Pilz, Julia B., Niess, Jan H., Delko, Tarik, Hruz, Petr, Cavelti-Weder, Claudia
Publicado 2021

Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity

por Melhem, Hassan, Kaya, Berna, Kaymak, Tanay, Wuggenig, Philipp, Flint, Emilio, Roux, Julien, Oost, Koen C., Cavelti-Weder, Claudia, Balmer, Maria L., Walser, Jean-Claude, Morales, Rodrigo A., Riedel, Christian U., Liberali, Prisca, Villablanca, Eduardo J., Niess, Jan Hendrik
Publicado 2022

CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice

por Bosch, Angela J. T., Keller, Lena, Steiger, Laura, Rohm, Theresa V., Wiedemann, Sophia J., Low, Andy J. Y., Stawiski, Marc, Rachid, Leila, Roux, Julien, Konrad, Daniel, Wueest, Stephan, Tugues, Sonia, Greter, Melanie, Böni-Schnetzler, Marianne, Meier, Daniel T., Cavelti-Weder, Claudia
Publicado 2023

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity

por Rohm, Theresa V., Keller, Lena, Bosch, Angela J. T., AlAsfoor, Shefaa, Baumann, Zora, Thomas, Amandine, Wiedemann, Sophia J., Steiger, Laura, Dalmas, Elise, Wehner, Josua, Rachid, Leila, Mooser, Catherine, Yilmaz, Bahtiyar, Fernandez Trigo, Nerea, Jauch, Annaise J., Wueest, Stephan, Konrad, Daniel, Henri, Sandrine, Niess, Jan H., Hruz, Petr, Ganal-Vonarburg, Stephanie C., Roux, Julien, Meier, Daniel T., Cavelti-Weder, Claudia
Publicado 2022

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

por Hepprich, Matthias, Mudry, Jonathan M., Gregoriano, Claudia, Jornayvaz, Francois R., Carballo, Sebastian, Wojtusciszyn, Anne, Bart, Pierre-Alexandre, Chiche, Jean-Daniel, Fischli, Stefan, Baumgartner, Thomas, Cavelti-Weder, Claudia, Braun, Dominique L., Günthard, Huldrych F., Beuschlein, Felix, Conen, Anna, West, Emily, Isenring, Egon, Zechmann, Stefan, Bucklar, Gabriela, Aubry, Yoann, Dey, Ludovic, Müller, Beat, Hunziker, Patrick, Schütz, Philipp, Cattaneo, Marco, Donath, Marc Y.
Publicado 2022